158 related articles for article (PubMed ID: 38625920)
21. The changing face of Irish head and neck cancer epidemiology: 20 years of data.
Sexton GP; Walsh P; Moriarty F; O'Neill JP
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):3079-3088. PubMed ID: 34647138
[TBL] [Abstract][Full Text] [Related]
22. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
23. Selective neck dissection in the treatment of head and neck squamous cell carcinoma patients with a clinically positive neck.
López F; Fernández-Vañes L; García-Cabo P; Grilli G; Álvarez-Marcos C; Llorente JL; Rodrigo JP
Oral Oncol; 2020 Mar; 102():104565. PubMed ID: 31945661
[TBL] [Abstract][Full Text] [Related]
24. The effectiveness of chemoradiation therapy and salvage surgery for hypopharyngeal squamous cell carcinoma.
Suzuki K; Hayashi R; Ebihara M; Miyazaki M; Shinozaki T; Daiko H; Sakuraba M; Zenda S; Tahara M; Fujii S
Jpn J Clin Oncol; 2013 Dec; 43(12):1210-7. PubMed ID: 24031082
[TBL] [Abstract][Full Text] [Related]
25. Disease trajectories, place and mode of death in people with head and neck cancer: Findings from the 'Head and Neck 5000' population-based prospective clinical cohort study.
Mayland CR; Ingarfield K; Rogers SN; Dey P; Thomas S; Waylen A; Leary SD; Pring M; Hurley K; Waterboer T; Pawlita M; Ness AR
Palliat Med; 2020 May; 34(5):639-650. PubMed ID: 32103703
[TBL] [Abstract][Full Text] [Related]
26. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011.
Braakhuis BJ; Leemans CR; Visser O
Oral Oncol; 2014 Jul; 50(7):670-5. PubMed ID: 24735546
[TBL] [Abstract][Full Text] [Related]
27. Surgical rescue for persistent head and neck cancer after first-line treatment.
Steinbichler TB; Golm L; Dejaco D; Riedl D; Kofler B; Url C; Wolfram D; Riechelmann H
Eur Arch Otorhinolaryngol; 2020 May; 277(5):1437-1448. PubMed ID: 31982945
[TBL] [Abstract][Full Text] [Related]
28. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
29. Impact of surgical resection on survival in patients with advanced head and neck cancer involving the carotid artery.
Manzoor NF; Russell JO; Bricker A; Koyfman S; Scharpf J; Burkey B; Khan MJ
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1219-25. PubMed ID: 24077023
[TBL] [Abstract][Full Text] [Related]
30. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery.
Wong LY; Wei WI; Lam LK; Yuen AP
Head Neck; 2003 Nov; 25(11):953-9. PubMed ID: 14603456
[TBL] [Abstract][Full Text] [Related]
31. Early Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database.
Jensen KH; Vogelius I; Kristensen CA; Andersen E; Overgaard J; Eriksen JG; Primdahl H; Johansen J; Farhadi M; Andersen M; Friborg J
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):57-63. PubMed ID: 32698963
[TBL] [Abstract][Full Text] [Related]
32. Outcome of Head and Neck Cancer Patients Who Did Not Receive Curative-Intent Treatment.
Shah D; Hoffman GR
J Oral Maxillofac Surg; 2017 Nov; 75(11):2456-2464. PubMed ID: 28460212
[TBL] [Abstract][Full Text] [Related]
33. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer.
El-Deiry M; Funk GF; Nalwa S; Karnell LH; Smith RB; Buatti JM; Hoffman HT; Clamon GH; Graham SM; Trask DK; Dornfeld KJ; Yao M
Arch Otolaryngol Head Neck Surg; 2005 Oct; 131(10):879-85. PubMed ID: 16230590
[TBL] [Abstract][Full Text] [Related]
34. Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.
Corry J; Bressel M; Fua T; Herschtal A; Solomon B; Porceddu SV; Wratten C; Rischin D
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):948-954. PubMed ID: 28483336
[TBL] [Abstract][Full Text] [Related]
35. Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancer.
Schutte HW; van den Broek GB; Steens SCA; Hermens RPMG; Honings J; Marres HAM; Merkx MAW; Weijs WLJ; Arens AIJ; van Engen-van Grunsven ACH; van Herpen CML; Kaanders JHAM; van den Hoogen FJA; Takes RP
Cancer; 2020 Sep; 126(17):3982-3990. PubMed ID: 32634271
[TBL] [Abstract][Full Text] [Related]
36. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.
Karp DD; Vaughan CW; Carter R; Willett B; Heeren T; Calarese P; Zeitels S; Strong MS; Hong WK
Am J Clin Oncol; 1991 Aug; 14(4):273-9. PubMed ID: 1713738
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer.
Kano S; Homma A; Hatakeyama H; Mizumachi T; Sakashita T; Kakizaki T; Fukuda S
Head Neck; 2017 Feb; 39(2):247-253. PubMed ID: 27617428
[TBL] [Abstract][Full Text] [Related]
38. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
[TBL] [Abstract][Full Text] [Related]
39. A risk factor for newly diagnosed secondary cancer in patients with early-stage laryngeal, oropharyngeal, or hypopharyngeal cancer: sub-analysis of a prospective observation study.
Nishimura G; Sano D; Arai Y; Takahashi H; Hatano T; Kitani Y; Takada K; Wada T; Hiiragi Y; Oridate N
Int J Clin Oncol; 2022 Mar; 27(3):488-494. PubMed ID: 34787745
[TBL] [Abstract][Full Text] [Related]
40. Concurrent cisplatin and radiation versus cetuximab and radiation for locally advanced head-and-neck cancer.
Koutcher L; Sherman E; Fury M; Wolden S; Zhang Z; Mo Q; Stewart L; Schupak K; Gelblum D; Wong R; Kraus D; Shah J; Zelefsky M; Pfister D; Lee N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):915-22. PubMed ID: 20947269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
